Description: NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
Home Page: www.natcopharma.co.in
Natco House
Hyderabad,
500034
India
Phone:
91 40 2354 7532
Officers
| Name | Title |
|---|---|
| Mr. Venkaiah Chowdary Nannapaneni M. Pharm, MS. | MD & Chairman |
| Mr. Rajeev Nannapaneni | CEO & Vice Chairman |
| Mr. S. V. V. N. Appa Rao | Chief Financial Officer |
| Dr. Donthineni Linga Rao M.D. | President of Technical Affairs & Whole Time Director |
| Mr. Chekuri Venkat Ramesh C.S. | Company Secretary & Compliance Officer |
| Mr. Potluri Sivaramakrishna Prasad | Executive VP of Corporate Engineering Services & Whole Time Director |
| Dr. Pavan Ganapati Bhat | Executive VP of Technical Operations & Director |
| Nadella Malleswara Rao | VP & Head of Operations |
| N. Sadasiva Rao | Executive Vice President of Corporate Affairs, Legal, Secretarial & Estate Management |
| James Rajakumar | Vice President of Marketing & Sales - Domestic |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 16.8634 |
|---|---|
| Trailing PE: | 13.3508 |
| Price-to-Book MRQ: | 3.6321 |
| Price-to-Sales TTM: | 5.6777 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 4016 |